Vogenx
Tracked across 1 events · 6 articles · First seen Sep 22, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Vogenx, Inc. (Nasdaq: VOGX), a clinical-stage biopharmaceutical company based in Raleigh, North Carolina, announced the appointment of Ken Toombs to its Board of Directors, effective September 21, 2026. Toombs will serve as an independent director…
Impact: Vogenx is the issuer announcing the appointment of Ken Toombs to its Board of Directors and Audit Committee chair, broadening independent oversight as it scales after its August 2026 IPO. The move is a minor positive governance signal for the clinical-stage biopharmaceutical company.
Sep 22, 2026 · 6 articles
90
Vogenx appointed to board Ken ToombsVogenx Appoints Ken Toombs to Board
ERGEN INTELLIGENCE
Track Vogenx live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard